Kinetics, Biodistribution, Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit, in Healthy Male Volunteers and Patients With Limited Recurrent Prostate Cancer

Trial Profile

Kinetics, Biodistribution, Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit, in Healthy Male Volunteers and Patients With Limited Recurrent Prostate Cancer

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 17 Aug 2017

At a glance

  • Drugs Gallium 68 PSMA (Primary)
  • Indications Prostate cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 10 Aug 2017 Status changed from not yet recruiting to withdrawn prior to enrolment as the ethics committee did not approved the start of the study
    • 10 Jul 2017 Planned initiation date changed from 30 Jun 2017 to 30 Jul 2017.
    • 20 Jun 2017 Planned initiation date changed from 16 Jun 2017 to 30 Jun 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top